ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      60,263.03
      1.74%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Kazia Therapeutics Ltd (KZIA)

      7. Kazia Therapeutics Ltd (KZIA) News

      KZIA

      Kazia Therapeutics (KZIA)

      Kazia Therapeutics Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:KZIA
      DateTimeSourceHeadlineSymbolCompany
      11/02/20167:06AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      11/02/20167:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      11/01/20167:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/31/20167:13AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/31/20167:09AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/31/20167:07AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/31/20167:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/30/201611:56PMPR Newswire (US)Novogen Acquires Privately-held Neuro-oncology Company to Support Development of GDC-0084 in GlioblastomaNASDAQ:KZIAKazia Therapeutics Ltd
      10/30/201611:43PMPR Newswire (US)Novogen Licenses Phase II-Ready Molecule from Genentech for Development in GlioblastomaNASDAQ:KZIAKazia Therapeutics Ltd
      10/30/201611:40PMPR Newswire (US)Novogen Acquires Privately-held Neuro-oncology Company to Support Development of GDC-0084 in GlioblastomaNASDAQ:KZIAKazia Therapeutics Ltd
      10/30/201611:35PMPR Newswire (US)Novogen Licenses Phase II-Ready Molecule from Genentech for Development in GlioblastomaNASDAQ:KZIAKazia Therapeutics Ltd
      10/27/20167:05AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:KZIAKazia Therapeutics Ltd
      10/26/20167:06AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/26/20167:03AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      10/17/20167:01AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      09/14/20167:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      09/14/20167:00AMPR Newswire (US)Conversion of Convertible NotesNASDAQ:KZIAKazia Therapeutics Ltd
      09/12/20167:07AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      09/12/20167:05AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      09/12/20167:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      09/12/20167:00AMPR Newswire (US)US FDA Approves Investigational New Drug (IND) Application for Cantrixil(TM) (TRX-E-002-1) in Ovarian CancerNASDAQ:KZIAKazia Therapeutics Ltd
      09/06/20166:09AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      09/06/20166:06AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      08/29/20167:03AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      08/11/20167:00AMPR Newswire (US)Novogen Submits Investigational New Drug (IND) Application to the US FDA For Cantrixil(TM) in Ovarian CancerNASDAQ:KZIAKazia Therapeutics Ltd
      08/11/20166:09AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      06/14/20168:07AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      06/14/20167:00AMPR Newswire (US)Novogen Patent Covering Anisina(TM) Has Proceeded to GrantNASDAQ:KZIAKazia Therapeutics Ltd
      05/02/20167:08AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KZIAKazia Therapeutics Ltd
      05/02/20167:00AMPR Newswire (US)Novogen Provides Update On Development Of CantrixilNASDAQ:KZIAKazia Therapeutics Ltd
       Showing the most relevant articles for your search:NASDAQ:KZIA